Acuvue Oasys for Astigmatism expands parameters

Article

Johnson & Johnson Vision Care, Inc. announced that effective April 15, 2014, Acuvue Oasys for Astigmatism will be available in more parameters.

Jacksonville, FL-Johnson & Johnson Vision Care, Inc. announced that effective April 15, 2014, Acuvue Oasys for Astigmatism will be available in more parameters.

Parameters are being expanded to include -6.00 D to +6.00 D in 0.25 D steps and from -6.50 D to -9.00 D in 0.50 D steps.

With the introduction of these new parameters, the company also announced that effective March 31, 2014, diagnostic lenses for Acuvue Advance for Astigmatism will no longer be available from Johnson & Johnson Vision Care, Inc.   

“In a clinical trial with Acuvue Advance for Astigmatism contact lens wearers, virtually 100% of patients had a prescription match and 100% of patients had first fit success with Acuvue Oasys for Astigmatism,” says W. Lee Ball, OD, FAAO, associate director, professional affairs, Johnson & Johnson Vision Care, Inc.  

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.